EMCREG-International Newsletter: Management of Life-Threatening Bleeding in the Anti-coagulated Patient in the Emergency Setting and the Impact of ANNEXA-4 on the Treatment of Patients Taking Factor Xa Inhibitors



Date & Location
Thursday, August 1, 2019, 12:00 AM - Saturday, August 15, 2020, 11:59 PM

Credits
AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)

Target Audience
Specialties - Cardiology, Emergency Medicine, Trauma/Critical Care

Overview
EMCREG-International Newsletter: Management of Life-threatening Bleeding in the Anticoagulated Patient


Registration

To to view this newsletter, please go to: https://www.emcreg.org/

There is no fee.


Objectives
As a result of participating in the enduring material activity, participants should be able to:

  1. Describe the results and significance of the ANNEXA-4 clinical trial of andexanet alfa in patients with severe bleeding due to Factor Xa inhibitors.
  2. Summarize the specific approaches to emergency management of bleeding related to oral anticoagulant therapy.
  3. Describe how this approach varies according to the particular oral anticoagulant, the urgency of the need for reversal, and the medical setting.
  4. Describe the mechanism of action of the anticoagulant reversal agents, idarucizumab and andexanet alfa.
  5. List the specific indications for the use of vitamin K, fresh frozen plasma, prothrombin complex concentrate, idarucizumab, and andexanet alfa in a patient with severe oral anticoagulant associated bleeding.

Accreditation

Accreditation and Designation Statement

This Activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and EMCREG-International. The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credits commensurate with the extent of their participation in the activity.


Additional Information

Disclaimer Statement

The opinions expressed during this activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.